• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮放射治疗在甲状腺乳头状癌初始治疗中的作用(作者译)

[Role of percutaneous radiotherapy in the primary treatment of papillary carcinomas of the thyroid gland (author's transl)].

作者信息

Wendt T

出版信息

Strahlentherapie. 1982 Jan;158(1):1-3.

PMID:7058535
Abstract

The value of post-operative percutaneous radiotherapy is examined by evaluating the case records of 27 patients with papillary carcinomas of the thyroid gland of stage pT4 NO MO and pT1-4 pN1-3 MO. A loco-regional disappearance was observed in 95% (20/21) of the post-irradiated patients. In half of all patients not post-irradiated, no loco-regional disappearance of the tumor was achieved; a formation of metastases was found later on in these patients. The percutaneous irradiation has been recommended for years by radiologists, but it is not accepted everywhere. The results suggest the necessity of radiotherapy in case of the above mentioned tumor stages.

摘要

通过评估27例pT4 NO MO期和pT1 - 4 pN1 - 3 MO期甲状腺乳头状癌患者的病例记录,对术后经皮放疗的价值进行了研究。在接受放疗的患者中,95%(20/21)出现了局部区域肿瘤消失。在所有未接受放疗的患者中,有一半没有实现肿瘤的局部区域消失;这些患者后来发现有转移灶形成。放射科医生多年来一直推荐经皮照射,但并非在所有地方都被接受。结果表明,对于上述肿瘤分期,放疗是必要的。

相似文献

1
[Role of percutaneous radiotherapy in the primary treatment of papillary carcinomas of the thyroid gland (author's transl)].经皮放射治疗在甲状腺乳头状癌初始治疗中的作用(作者译)
Strahlentherapie. 1982 Jan;158(1):1-3.
2
[Indications for percutaneous radiotherapy in carcinoma of the thyroid gland. Freiburg consensus].[甲状腺癌经皮放射治疗的适应证。弗莱堡共识]
Radiologe. 1995 Aug;35(8):535-9.
3
Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.肿瘤分期超过T1N0M0的甲状腺乳头状癌的治疗结果
Radiother Oncol. 2008 Oct;89(1):97-104. doi: 10.1016/j.radonc.2008.05.011. Epub 2008 Jun 3.
4
Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS).局部晚期分化型甲状腺癌辅助放疗的急性毒性。多中心分化型甲状腺癌研究(MSDS)的初步结果。
Strahlenther Onkol. 2003 Dec;179(12):832-9. doi: 10.1007/s00066-003-1158-1.
5
[Teleradiotherapy in the treatment of thyroid neoplasms].[远距离放射治疗在甲状腺肿瘤治疗中的应用]
Chir Ital. 1994;46(4):61-5.
6
[Papillary carcinoma of the thyroid gland (author's transl)].甲状腺乳头状癌(作者译)
Wien Klin Wochenschr. 1980 Feb 15;92(4):113-8.
7
[Beam radiotherapy in treatment of thyroid carcinoma (author's transl)].[束流放射疗法治疗甲状腺癌(作者译)]
Radiol Med. 1980 Jul-Aug;66(7-8):527-35.
8
Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.甲状腺微小乳头状癌——淋巴结转移和多灶性的预后意义
Cancer. 2003 Jul 1;98(1):31-40. doi: 10.1002/cncr.11442.
9
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.外照射放疗在晚期或复发性非间变性甲状腺癌患者中的作用:纪念斯隆凯特琳癌症中心的经验
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):795-801. doi: 10.1016/j.ijrobp.2008.05.012.
10
[Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].[分化型甲状腺癌的治疗理念——257例患者25年的治疗结果]
Praxis (Bern 1994). 2000 Nov 2;89(44):1779-97.